Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 6, 2001 - Issue 3
Submit an article Journal homepage
264
Views
39
CrossRef citations to date
0
Altmetric
Reviews

Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role

J. NeuzilDivision of Pathology II University Hospital, Linköping , Sweden
,
T. WeberInstitute for Prevention of Cardiovascular Diseases Ludwig Maximilians University, Munich , Germany
,
A. TermanDivision of Pathology II University Hospital, Linköping , Sweden
,
C. WeberInstitute for Prevention of Cardiovascular Diseases Ludwig Maximilians University, Munich , Germany
&
U.T. BrunkDivision of Pathology II University Hospital, Linköping , Sweden
Pages 143-151 | Published online: 19 Jul 2013

  • Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990; 10: 357–382.
  • Azzi A, Stocker A. Vitamin E: non-antioxidant roles. Progr Lipid Res 2000; 39: 231–255.
  • Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by a-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997; 22: 57–71.
  • Haendeler J, Zeiher AM, Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bc1-2 and Bax. Eur J Pharmacol 1996; 317: 407–411.
  • Neuzil J, Weber T, Schroder A et al. Induction of apoptosis in cancer cells by a-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 2001; 15: 403–415.
  • Qian M, Kralova J, Yu W et al. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 1997; 15: 223–230.
  • Neuzil J, Svensson I, Weber T, Weber C, Brunk UT. a-Tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondria' destabilisation. FEBS Lett 1999; 445: 295–300.
  • Djuric Z, Heilbrun LK, Lababidi S, Everett-Bauer CK, Fariss MW. Growth inhibition of MCF-7 and MCF-10A human breast cells by a-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Lett 1997; 111: 133–139.
  • Jha MN, Bedford JS, Cole WC, Edward-Prasad J, Prasad KN. Vitamin E (d-a-tocopheryl succinate) decreases mitotic accumulation in 7-irradiated human tumor but not in normal cells. Nutr Cancer 1999; 35: 189–194.
  • Neuzil J, Weber T, Gellert N, Weber C. Selective cancer cell killing by a-tocopheryl succinate. Br J Cancer 2001; 84: 87–89.
  • Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239–2244.
  • Nathan I, Dizdaroglu M, Bernstein L, Junker U, Lee CK, Muegge K, Durum SK. Induction of oxidative DNA damage in U937 cells by TNF or anti-Fas stimulation. Cytokine 2000; 12: 881–887.
  • Suzuki Y, Ono Y, Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett 1998; 425: 209–212.
  • Mabile L, Fitoussi G, Periquet B, Schmitt A, Salvayre R, Negre-Salvayre A. a-Tocopherol and Trolox block the early intracellular events elicited by oxidized low density lipoproteins in cultured endothelial cells. Free Radic Biol Med 1995; 19: 177–187.
  • de Nigris F, Franconi F, Maida I, Palumbo G, Anania V, Napoli C. Modulation by a- and 7-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells. Biochem Pharmacol 2000; 59: 1477–1487.
  • Lizard G, Miguet C, Bessede Get al. Impairment with various antioxidants of the loss of mitochondria' transmembrane potential and of the cytosolic release of cytochrome c occuring during 7-ketocholesterol-induced apoptosis. Free Radic Biol Med 2000; 28: 743–753.
  • Chen Q, Cederbaum Al. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in HepG2 cells. Mol Pharmacol 1998; 53: 638–648.
  • Chan SL, Tammariello SP, Estus S, Mattson MP. Prostate apoptosis response-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondria' dysfunction and caspase activation. J Neurochem 1999; 73: 502–512.
  • Tagami M, Ikeda K, Yamagata K et al. Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke prone spontaneously hypertensive rats. Lab Invest 1999; 79: 609–615.
  • Weber T, Dalen H, Terman A et al. Mitochondria play a central role in a-tocopheryl succinate-induced apoptosis in malignant cells. 2001: Submitted.
  • Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z. The selective antiproliferative effects of a-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 1994; 54: 3346–3351.
  • Tirmenstein MA, Ge X, Elkins CR, Fariss MW. Administration of the Tris salt of a-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal a-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity. Free Radic Biol Med 1999; 26: 825–835.
  • Zhao B, Yu W, Qian M et al. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinog 1997; 19: 180–190.
  • Yu W, Simmons-Menchaca M, You H et al. RRR-a-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog 1998; 22: 247–257.
  • Turley JM, Funakoshi S, Ruscetti FW et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor-P. Cell Growth Differ 1995; 6: 655–663.
  • Ottino P, Duncan JR. Effect of a-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic Biol Med 1997; 22: 1145–1151.
  • Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem 1998; 252: 1–15.
  • Susin SA, Daugas E, Ravagnan L et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000; 192: 571–580:
  • Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bc1-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481–490.
  • Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-l/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489.
  • Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999; 274: 20049–20052.
  • Ferrari D, Stepczynska A, Los M, Wesselborg S, Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med 1998; 188: 979–984.
  • Roberg K, 011inger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998; 152: 1151–1156.
  • O11inger K, Brunk UT. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic Biol Med 1995; 19: 565–574.
  • Shibata M, Kanamori S, Isahara K et al. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 1998; 251: 199–203.
  • Ishisaka R, Utsumi T, Yabuki M et al. Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett 1998; 435: 233–236.
  • Monney L, Olivier R, Otter I, Jansen B, Poirier GO, Borner C. Role of an acidic compartment in tumor-necrosis-factor-a-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem 1998; 251: 295–303.
  • Wu GS, Saftig P, Peters C, El-Deiry WS. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998; 16: 2177–2183.
  • Roberg K, Johansson U, 011inger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 1999; 27: 1228–1237.
  • Li W, Yuan X, Nordgren Get al. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 2000; 470: 35–39.
  • Heinrich M, Wickel M, Winoto-Morbach S et al. Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol 2000; 477: 305–315.
  • Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998; 332: 281–292.
  • Ron D, Kazanietz MG. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999; 13: 1658–1676.
  • Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24: 186–191.
  • Haimovitz-Friedman A, Balaban N, McLoughlin M et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994; 54: 2591–2597.
  • Chen CY, Faller DV. Selective inhibition of protein kinase C isozymes by Fos ligation. J Biol Chem 1999; 274: 15320–15328.
  • Santoro MF, Armand RR, Robertson MM et al. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 1998; 273: 13119–13128.
  • Lee JY, Hannun YA, Obeid LM. Ceramide inactivates cellular protein kinase C-a. J Biol Chem 1996; 271: 13169–13174.
  • Ruvolo PP, Deng X, Ito T, Can BK, May WS. Ceramide induces bc1-2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274: 20296–20300.
  • Ruiz-Ruiz C, Robledo G, Font J, Izquierdo M, Lopez-Rivas A. Protein kinase C inhibits CD95 (Fas/AP0-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells. J Immunol 1999; 163: 4737–4746.
  • Whelan RD, Parker PJ. Loss of protein kinase C function induces an apoptotic response. Oncogene 1998; 16: 1939–1944.
  • Mayne GC, Murray AW. Evidence that protein kinase C-E mediates phorbol ester inhibition of calphostin C- and tumour necrosis factor-a-induced apoptosis in U937 histiocytic lymphoma cells. J Biol Chem 1998; 273: 24115–24121.
  • Ruvolo PP, Deng X, Can BK, May WS. A functional role for mitochondrial protein kinase C-a in bc1-2 phosphorylation and suppression of apoptosis. J Biol Chem 1998; 273: 25436–25442.
  • Watters DJ, Parsons PG. Critical targets of protein kinase C in differentiation of tumour cells. Biochem Pharmacol 1999; 58: 383–388.
  • Ways DK, Kukoly CA, deVente J et al. MCF-7 breast cancer cells transfected with protein kinase C-a exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995; 95: 1906–1915.
  • Kolch W, Heidecker G, Kochs G et al. Protein kinase C-a activates RAF-1 by direct phosphorylation. Nature 1993; 364: 249–252.
  • Livneh E, Fishman DD. Linking protein kinase C to cell-cycle control. Eur J Biochem 1997; 248: 1–9.
  • Nakaigawa N, Hirai S, Mizuno K, Shuin T, Hosaka M, Ohno S. Differential effects of overexpression of PKCa and PKCS/E on cellular E2F activity in late G1 phase. Biochem Biophys Res Commun 1996; 222: 95–100.
  • de Vente JE, Kukoly CA, Bryant WO et al. Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death. J Clin Invest 1995; 96: 1874–1886.
  • Frey MR, Saxon ML, Zhao X, Rollins A, Evans SS, Black JD. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21WmP-1 and p27K'Pl and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem 1997; 272: 9424–9435.
  • O'Connor L, Huang DC, O'Reilly LA, Strasser A. Apoptosis and cell division. Curr Opinion Cell Biol 2000; 12: 257–263.
  • Harvey KJ, Lukovic D, Ucker DS. Caspase-dependent Cdk activity is a requisite effector of apoptotic death events. J Cell Biol 2000; 148: 59–72.
  • Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC .Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 1997; 57: 2668–2675.
  • Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bc1-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996; 183: 2219–2226.
  • Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A. d-a-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA 1995; 92: 12190–12194.
  • Cachia 0, El Benna J, Perduzzi E, Descombs B, Gougerot-Pocidalo MA, Leger CL. a-Tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47Ph0” membrane translocation and phosphorylation. J Biol Chem 1998; 273: 32801–32805.
  • Li Q, Subbulakshmi V, Fields AP, Murray NR, Cathcart MK. Protein kinase C-a regulates human monocyte 02- production and low density lipoprotein lipid oxidation. J Biol Chem 1999; 274: 3764–3771.
  • Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A. a-Tocopherol specifically inactivates cellular protein kinase C-a by changing its phosphorylation state. Biochem J 1998; 334: 243–249.
  • Neuzil J, Weber T, Lu M et al. Vitamin E succinate: a potent new anti-neoplastic agent with high tumor selectivity. 2001; Submitted.
  • Gogu SR, Lertora JJ, George WJ, Hyslop NE, Agrawal KC. Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E. Exp Hematol 1991; 19: 649–652.
  • Albanes D, Malila N, Taylor PR et al. Effects of supplemental a-tocopherol and 3-carotene on colorectal cancer: results from a controlled trial. Cancer Causes Control 2000; 11: 197–205.
  • Factor VM, Laskowska D, Jensen MR, Woitach JT, Popescu NC, Thorgeirsson SS. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2000; 97: 2196–2201.
  • Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ. Antioxidants enhance the toxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21Maic'P-1 via C/EBPP. Nat Med 1997; 3: 1233–1241.
  • Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000; 93: 163–170.
  • Pussinen PJ, Lindner H, Glatter 0 et al. Lipoprotein-associated a-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta 2000; 1485: 129–144.
  • Fariss MW, Bryson KF, Hylton EE, Lippman HR, Stubin CH, Thao XG. Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol. Environ Health Perspect 1993; 101: 528–536.
  • Traber MG, Ramakrishnan R, Kayden HJ. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-a-tocopherol. Proc Natl Acad Sci USA 1994; 91: 10005–10008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.